Top Story

Oncology Nursing Society to kick off its 40th Annual Congress

April 17, 2015

The Oncology Nursing Society will kick off its 2015 Annual Congress on Wednesday, April 22 in Orlando, Fla., marking its 40th year of providing comprehensive nursing oncology education, research and practice information.
According to Oncology Nursing Society (ONS) Congress Planning Team Chair Nonniekaye Shelburne, CNRP, the program and presenters for this year’s meeting will cover the hottest topics in oncology care.
“Notable changes in 2015 include a dedicated nurse researcher track, over 25 of the 140 posters presented electronically as e-posters, live streaming of select sessions, and session rooms set up to facilitate interactive presentations between presenters and attendees,” Shelburne said in an interview with HemOnc Today.

Focus on the future

FDA News

FDA grants orphan drug designation to Samcyprone for malignant stage IIb to IV melanoma

April 17, 2015
RXi Pharmaceuticals announced it has received orphan drug designation from the FDA for Samcyprone, its clinical candidate for treating malignant melanoma stage IIb to…
FDA News

FDA grants orphan drug designation to Reolysin for malignant gliomas

April 17, 2015
The FDA today granted orphan drug designation to pelareorep for the treatment of patients with malignant gliomas, according to a press release from the drug’s…
Sunit Das, MD, PhD In the Journals

Hypofractionated radiation, temozolomide effective in elderly patients with glioblastoma

April 17, 2015
Hypofractionated radiotherapy or temozolomide monotherapy may be a viable treatment option for elderly patients with glioblastoma multiforme, according to results of a…
Meeting News Coverage

Erlotinib, bevacizumab yield negligible outcome in metastatic melanoma

April 17, 2015
NEW YORK — The combination of erlotinib and bevacizumab was tolerable yet displayed minimal clinical activity in patients with metastatic melanoma, according to…
More News Headlines »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
VIDEO: Ongoing phase 3 trial evaluates patient-specific vaccine in metastatic melanoma

VIDEO: Ongoing phase 3 trial evaluates patient-specific vaccine in metastatic melanoma

April 12, 2015
Robert O. Dillman, MD, vice president of oncology at NeoStem Inc., provides an overview of a phase 3 trial evaluating…
More »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »